Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7543449rdf:typepubmed:Citationlld:pubmed
pubmed-article:7543449lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C0449450lld:lifeskim
pubmed-article:7543449lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:7543449pubmed:issue1lld:pubmed
pubmed-article:7543449pubmed:dateCreated1995-9-11lld:pubmed
pubmed-article:7543449pubmed:abstractTextThe peptidic nature of the male (H-Y) antigen, a model minor histocompatibility antigen in H-2b mice, has recently been demonstrated. In this study we show that the H-Y peptide, which is recognized by PM-1, a Db-restricted cytotoxic T-lymphocyte (CTL) clone, is absent in male H-2d spleen cells but present in male H-2d spleen cells that also express a transgenic Db molecule under its endogenous promoter. This result indicates that both the H-Y and the Db gene products are essential and sufficient for production of the Db-restricted H-Y peptide. By comparing the ability of the PM-1 clone and bulk CTL generated in a secondary mixed lymphocyte culture to recognize H-Y peptidic material eluted from affinity-purified Db molecules and separated by reversed-phase high-performance liquid chromatography (HPLC), we provide evidence that there is an immunodominant H-Y epitope that is presented by the Db molecule. Furthermore, the presentation of this epitope is not affected by a mutation in the alpha 3 domain of Db (asp227 to lys227), which abrogates CD8 binding, since similar amounts of H-Y peptide were eluted from affinity-purified wild-type or mutant Db molecules. However, the generation of the H-Y epitope is dependent on the presence of beta 2-microglobulin, since it is absent in male H-2b mice that lack a functional beta 2-microglobulin gene. The implications of these findings on T-cell development are discussed.lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:languageenglld:pubmed
pubmed-article:7543449pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:citationSubsetIMlld:pubmed
pubmed-article:7543449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7543449pubmed:statusMEDLINElld:pubmed
pubmed-article:7543449pubmed:monthMaylld:pubmed
pubmed-article:7543449pubmed:issn0019-2805lld:pubmed
pubmed-article:7543449pubmed:authorpubmed-author:TehH SHSlld:pubmed
pubmed-article:7543449pubmed:authorpubmed-author:TamS WSWlld:pubmed
pubmed-article:7543449pubmed:authorpubmed-author:KilleenNNlld:pubmed
pubmed-article:7543449pubmed:authorpubmed-author:DutzJ PJPlld:pubmed
pubmed-article:7543449pubmed:issnTypePrintlld:pubmed
pubmed-article:7543449pubmed:volume85lld:pubmed
pubmed-article:7543449pubmed:ownerNLMlld:pubmed
pubmed-article:7543449pubmed:authorsCompleteYlld:pubmed
pubmed-article:7543449pubmed:pagination74-81lld:pubmed
pubmed-article:7543449pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:meshHeadingpubmed-meshheading:7543449-...lld:pubmed
pubmed-article:7543449pubmed:year1995lld:pubmed
pubmed-article:7543449pubmed:articleTitleA mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide.lld:pubmed
pubmed-article:7543449pubmed:affiliationDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.lld:pubmed
pubmed-article:7543449pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7543449pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:83772entrezgene:pubmedpubmed-article:7543449lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7543449lld:pubmed
More...